2025 Active Grants
National Institute of Drug Abuse (NIDA)
15/21 Adolescent Brain Cognitive Development (ABCD)-USA Consortium: Research Project Site at LIBR
04/15/2020 – 03/31/2027 Principal Investigators: Martin Paulus, M.D. and Robin Aupperle, Ph.D. U01DA050989 (co-funded by NIAAA) Plasticity of Aversive Salience in Opioid Use Disorder 03/01/2021 – 12/31/2025 Principal Investigator: Jennifer Stewart, Ph.D. R01DA050677 Kipiyecipakiciipe “coming home”: Establishing clinical cultural neuroscience as a tool for understanding the role of traditional cultural engagement in mitigating substance misuse and disorder 07/01/2023 – 05/31/2028 Principal Investigator: Evan White, Ph.D DP1DA058986 Interoceptive mechanisms of body image disturbance in anorexia nervosa 12/01/2023 – 11/30/2028 Principal Investigator: Emily Choquette K23MH135213 
National Institute of General Medical Sciences (NIGMS)
The Center for Neuroscience-based Mental Health Assessment and Prediction (NeuroMAP)
09/15/2017 - 06/30/2028 Principal Investigator: Martin Paulus, M.D. P20GM121312 
NIH: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
05/01/2023 – 04/30/2026 Principal Investigators: Robin Aupperle, Ph.D (LIBR), Charles Taylor, Ph.D. (UCSD) R34AA030688 
Wellbeing for Planet Earth Foundation, Japan
Using active inference to uncover the neurocomputational mechanisms that contribute to well-being and their potential differences across diverse populations
04/09/2022 – 04/08/2025 Principal Investigator: Ryan Smith, Ph.D. |
National Institute of Mental Health (NIMH)
Neural Response to Inflammatory Challenge in Major Depressive Disorder
05/14/2021 – 4/20/2026 Principal Investigator: Jonathan Savitz, Ph.D. R01MH123652 (co-funded by NIAID) A Neurocomputational Assay of Gastrointestinal Interoception in Anorexia Nervosa 09/01/2021 – 06/20/2027 Principal Investigator: Martin Paulus, M.D., Sahib Khalsa, M.D., Ph.D (Contact) R01MH127225 (Co-funded by the National Institute for General Medical Science (NIGMS)) An Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome in Anxiety and Depression 07/01/2020 - 06/30/2025 Principal Investigator: Robin Aupperle, Ph.D. R01MH123691 In Vivo Inflammatory Challenge to Elucidate the Roll of the Toll-like Receptor 4 Pathway in Depression 04/01/2022 – 04/30/2027 Principal Investigator: Leandra Figueroa-Hall R00MH126950 Effects of Pandemic-related Disruption to Social Connectedness on the Brain and Emotional Wellbeing in Adolescents 06/01/2022 – 12/30/2026 Principal Investigators: Chun Chieh Fan, M.D., Ph.D. and Wesley Thompson, Ph.D. R01MH128959 Identifying and Quantifying Genetic Effects on Neurodevelopmental Trajectories in Adolescents 06/01/2022 – 01/31/2026 (NCE) Principal Investigator: Chun Chieh Fan, M.D., Ph.D. R01MH122688 Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Comorbid Anxiety and Depression 03/15/2023 – 12/31/2027 Principal Investigator: Maria Ironside, D.Phil. R01MH132565 Cytomegalovirus, Brain Alterations, and Depression: Decoding Neuroinflammatory Pathways for Effective Intervention 05/17/2024 – 04/30/2028 Principal Investigator: Haixia Zheng, Ph.D. K01MH136403 Dose-Dependent Functional Connectivity Effects of Low-Intensity Focused Ultrasound Applied to Deep White Matter Tracts in Humans 12/01/2024 – 11/30/2026 Principal Investigator: Salvador Guinjoan, M.D., Ph.D. R21MH138911 
National Institute on Minority Health and Health Disparities (NIMHD)
Neuroscientific Exploration of Cultural Protective Factors in American Indians
12/01/2022 – 11/30/2025 Principal Investigator: Evan White, Ph.D. R00MD015736 |
